Recombinant CRLF2 (Verekitug Biosimilar) antibody

Catalog No. ABIN7598089

The Human Monoclonal anti-CRLF2 (Verekitug Biosimilar) antibody is suitable to detect CRLF2 (Verekitug Biosimilar) in samples from Human.

Quick Overview for Recombinant CRLF2 (Verekitug Biosimilar) antibody (ABIN7598089)

Target: CRLF2 (Verekitug Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Verekitug Biosimilar Antibody

Specificity: Cytokine receptor-like 2, CRLF2, CRL2, Thymic stromal lymphopoietin protein receptor, Cytokine receptor-like factor 2, TSLPR, ILXR, IL-XR, TSLP receptor

Purification: Protein A purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: CRLF2 (Verekitug Biosimilar)

Alternative Name: Verekitug Biosimilar

Target Type: Biosimilar

Background: Cytokine receptor-like 2, CRLF2, CRL2, Thymic stromal lymphopoietin protein receptor, Cytokine receptor-like factor 2, TSLPR, ILXR, IL-XR, TSLP receptor

UniProt: Q9HC73

CAS-No: 2768386-15-6